These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4843233)

  • 1. Automated radiometric assays of enzymatic and nonenzymatic oxidation of DOPA in vitro.
    Tran N
    J Lab Clin Med; 1974 Aug; 84(2):287-91. PubMed ID: 4843233
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of enzymatic and nonenzymatic oxidation of DOPA in vitro.
    Tran N
    J Nucl Med; 1972 Jun; 13(6):349-52. PubMed ID: 5024785
    [No Abstract]   [Full Text] [Related]  

  • 3. The enzymatic decarboxylation of DOPA in human liver homogenates.
    Vogel WH; Snyder R; Hare TA
    Proc Soc Exp Biol Med; 1970 Jun; 134(2):477-81. PubMed ID: 5310151
    [No Abstract]   [Full Text] [Related]  

  • 4. A tyrosine hydroxylase assay in microwells using coupled nonenzymatic decarboxylation of dopa.
    Bostwick JR; Le WD
    Anal Biochem; 1991 Jan; 192(1):125-30. PubMed ID: 1675553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates.
    Vogel WH; Mahoney K; Hare TA
    Arch Int Pharmacodyn Ther; 1972; 198(1):85-93. PubMed ID: 4538242
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of pyridoxal phosphate and L-dopapyridoxal phosphate on DOPA decarboxylase activity.
    Tran N
    Experientia; 1972 Sep; 28(9):1021-2. PubMed ID: 4665286
    [No Abstract]   [Full Text] [Related]  

  • 7. [Production of non-enzymatic 14CO2 from DL-DOPA-carboxyl-14C in the presence of liver and brain homogenates].
    Laplante M; Tran N
    Arch Int Pharmacodyn Ther; 1973 Jun; 203(2):259-64. PubMed ID: 4742829
    [No Abstract]   [Full Text] [Related]  

  • 8. (18F) Fluoro-Dopa: a unique gamma emitting substrate for Dopa decarboxylase.
    Firnau G; Garnett ES; Sourkes TL; Missala K
    Experientia; 1975 Nov; 31(11):1254-5. PubMed ID: 1204761
    [No Abstract]   [Full Text] [Related]  

  • 9. Decarboxylation of 3,4-dihydroxyphenylalanine by oxyhemoglobin.
    Yamabe H; Lovenberg W
    Biochem Biophys Res Commun; 1972 May; 47(4):733-9. PubMed ID: 5063594
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative metabolism of D-and L-3,4-dihydroxyphenylalanine in normal and pyridoxine-deficient rats.
    Sourkes TL; Wiseman-Distler H; Moran JF; Murphy GF; Saint Cyr S
    Biochem J; 1964 Dec; 93(3):469-74. PubMed ID: 5839180
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of analogs of phenylalanine and tryptophan on kinetics of DOPA decarboxylase in rat brain.
    De Ropp RS; Furst A
    Brain Res; 1966 Oct; 2(4):323-32. PubMed ID: 5298124
    [No Abstract]   [Full Text] [Related]  

  • 12. L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro.
    Rivera-Calimlim L; Morgan JP; Dujovne CA; Bianchine JR; Lasagna L
    Biochem Pharmacol; 1971 Nov; 20(11):3051-7. PubMed ID: 5132112
    [No Abstract]   [Full Text] [Related]  

  • 13. Further evaluation of continuous-flow ionization chamber method for DOPA decarboxylase assay.
    Tran N; LeBel E
    J Nucl Med; 1973 Dec; 14(12):924-7. PubMed ID: 4753453
    [No Abstract]   [Full Text] [Related]  

  • 14. New pathway for metabolism of dopa.
    O'Leary MH; Baughn RL
    Nature; 1975 Jan; 253(5486):52-3. PubMed ID: 1167399
    [No Abstract]   [Full Text] [Related]  

  • 15. Accurate assay of dopa decarboxylase by preventing nonenzymatic decarboxylation of dopa.
    Okuno S; Fujisawa H
    Anal Biochem; 1983 Mar; 129(2):412-5. PubMed ID: 6405659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of radiometric methods for in vitro detection of metabolic diseases in human beings].
    Tran N; Laplante M; Lebel E
    Union Med Can; 1973 Aug; 103(8):1656-9. PubMed ID: 4792853
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavior of fluorinated analogs of L-(3,4-dihydroxyphenyl)alanine and L-threo-(3,4-dihydroxyphenyl)serine as substrates for Dopa decarboxylase.
    Borri Voltattorni C; Bertoldi M; Bianconi S; Deng WP; Wong K; Kim I; Herbert B; Kirk KL
    Biochem Biophys Res Commun; 2002 Jul; 295(1):107-11. PubMed ID: 12083775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DOPA-DOPP-transaminases of rat brain in vitro].
    Gey KF
    Helv Physiol Pharmacol Acta; 1967; 25(2):CR187-9. PubMed ID: 5588161
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding of 14C-labeled dopa by Mycobacterium leprae in vitro.
    Prabhakaran K; Harris EB; Kirchheimer WF
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):58-64. PubMed ID: 819383
    [No Abstract]   [Full Text] [Related]  

  • 20. SUBSTRATE SPECIFICITY OF DOPA DECARBOXYLASE.
    AWAPARA J; PERRY TL; HANLY C; PECK E
    Clin Chim Acta; 1964 Sep; 10():286-9. PubMed ID: 14205921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.